| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.26B | 44.26B | 50.07B | 48.71B | 57.34B | 42.08B |
| Gross Profit | 2.50B | 2.67B | 3.49B | 3.13B | 3.20B | 2.80B |
| EBITDA | 2.63B | 2.81B | 2.68B | 3.05B | 2.78B | 1.91B |
| Net Income | 195.00M | 260.00M | 103.00M | 198.00M | 168.00M | 60.00M |
Balance Sheet | ||||||
| Total Assets | 32.76B | 31.28B | 27.76B | 28.60B | 29.21B | 29.98B |
| Cash, Cash Equivalents and Short-Term Investments | 172.00M | 329.00M | 349.00M | 453.00M | 404.00M | 456.00M |
| Total Debt | 11.58B | 11.49B | 7.93B | 8.03B | 8.82B | 9.64B |
| Total Liabilities | 18.81B | 17.06B | 13.44B | 13.63B | 14.57B | 15.80B |
| Stockholders Equity | 1.27B | 1.34B | 1.35B | 1.55B | 1.52B | 1.53B |
Cash Flow | ||||||
| Free Cash Flow | 2.12B | 2.29B | 1.84B | 2.14B | 1.95B | 1.66B |
| Operating Cash Flow | 2.71B | 2.93B | 2.48B | 2.72B | 2.40B | 1.99B |
| Investing Cash Flow | -2.81B | -3.36B | -875.00M | -702.00M | -526.00M | 386.00M |
| Financing Cash Flow | -168.00M | 399.00M | -1.70B | -1.97B | -1.93B | -1.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $18.12B | 12.00 | 34.98% | 9.13% | 11.43% | -8.64% | |
80 Outperform | $15.18B | 26.36 | 9.82% | 2.70% | 22.22% | 23.30% | |
76 Outperform | $8.26B | 14.33 | 64.33% | 8.45% | 7.06% | 13.61% | |
73 Outperform | $10.49B | 22.84 | 20.38% | 4.98% | 8.14% | -0.91% | |
70 Outperform | $16.46B | 25.93 | 11.77% | 8.54% | -9.94% | 43.70% | |
66 Neutral | $19.14B | 60.09 | 14.67% | 8.03% | -9.94% | 34.19% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |